Multiple Sclerosis (MS) Drugs
Rebif ® Unknowns (interferon beta-1a)
Unknowns of Rebif ® (interferon beta-1a)
2002 – A patient with Multiple Sclerosis can expect to live to average population life-expectancy minus seven years (mean life expectancy - 7 years).
Early Symptoms
The nature of multiple sclerosis and the vagueness of a symptom appearing here or there over time, without any apparent connection means there is a lack of data on what can accurately be considered as early symptom of multiple sclerosis... Read More
Welcome to the new look site.